Главная › Рак молочной железы › Огайо › Columbus
Клинические исследования Рак молочной железы в городе Columbus, OH
40 исследований по теме Рак молочной железы ищут участников в центрах в городе Columbus и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- The Ohio State University, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- и еще 8
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Набор участниковФаза 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Набор участниковФаза 1
- James Cancer Hospital and Solove Research Institute, Columbus
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Набор участниковФаза 1/2
- Local Institution - 0102, Columbus
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Набор участниковФаза 3
- Clinical Trial Site, Columbus
- Clinical Trial Site, Columbus
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Набор участниковФаза 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Набор участниковФаза 1
- The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc., Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Набор участниковФаза 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Набор участниковФаза 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- и еще 8
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Набор участниковФаза 2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набор участниковФаза 3
- Ohio State University Comprehensive Cancer Center, Columbus
E-Mindfulness Approaches for Living After Breast Cancer
Набор участниковФаза 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Mount Carmel Grove City Hospital, Grove City · 7 миль отсюда
- и еще 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Набор участниковФаза 1/2
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Набор участниковФаза 2Приглашаются здоровые добровольцы
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Набор участниковФаза 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Набор участниковФаза 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
Набор участниковФаза 4
- Ohio State University Comprehensive Cancer Center, Columbus
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Набор участниковФаза 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer
Набор участников
- The Ohio State University, Columbus
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Набор участниковФаза 3
- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - , Columbus
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Набор участниковНаблюдательное исследование
- Ohio State University Comprehensive Cancer Center, Columbus
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Набор участниковФаза 1
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Набор участниковФаза 2
- Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Набор участниковФаза 3
- Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Набор участниковФаза 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Набор участниковФаза 2
- Ohio State University Medical Center, Columbus
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Набор участниковФаза 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Riverside Methodist Hospital, Columbus
- и еще 8
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Набор участниковНаблюдательное исследование
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Набор участниковФаза 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Living Well With Advanced Breast Cancer
Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы
- Ohio State University Comprehensive Cancer Center, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набор участниковНаблюдательное исследование
- Memorial Hospital, Marysville · 27 миль отсюда
Feasibility Study of CBCT for IGRT in Cancer Patients
Набор участников
- James Outpatient Center, Columbus
- Ohio State University, Brain and Spine Hospital, Columbus
- The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus
- и еще 1
The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
Набор участниковНаблюдательное исследование
- Ohio State University Comprehensive Cancer Center, Columbus
The Ohio State University (OSU) SCREEN Community Program
Набор участниковПриглашаются здоровые добровольцы
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Набор участниковФаза 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
Набор участниковФаза 2
- The Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, Columbus
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
Набор участников
- Ohio State University Comprehensive Cancer Center, Columbus
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
Набор участниковНаблюдательное исследование
- Mount Carmel West Hospital, Columbus
Исследования Рак молочной железы в других городах
- New York City, NY136 исследований
- Houston, TX126 исследований
- Boston, MA112 исследований
- Nashville, TN81 исследование
- Los Angeles, CA73 исследований
- Edison, NJ68 исследований
- St. Louis, MO64 исследований
- Queens, NY64 исследований
- Durham, NC64 исследований
- Chicago, IL59 исследований
- Philadelphia, PA56 исследований
- Dallas, TX55 исследований
Другие исследования в городе Columbus
- Немелкоклеточный рак легкого57 исследований
- Рак яичников39 исследований
- Рак (все виды)38 исследований
- Рак легких37 исследований
- Острый миелоидный лейкоз35 исследований
- Хронический лимфоцитарный лейкоз28 исследований
- Метастатический рак27 исследований
- Рак эндометрия25 исследований
- Рак простаты24 исследований
- Множественная миелома24 исследований
- Колоректальный рак24 исследований
- Меланома21 исследование
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.